Covered recipient · General Payments record
MARC I WITTENBERG
Allopathic & Osteopathic Physicians Pain Medicine Pain Medicine
General Payments · PY2018–2024
$3,456.32
- Reported across 173 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $788.84 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Nevro Corp. | $535.51 | 23 |
| ABBVIE INC. | $149.45 | 6 |
| Nalu Medical, Inc. | $40.43 | 2 |
| Pacira Pharmaceuticals Incorporated | $19.93 | 1 |
| BIOTISSUE HOLDINGS INC. | $17.51 | 1 |
| Collegium Pharmaceutical, Inc. | $16.14 | 1 |
| Saluda Medical Americas, Inc. | $9.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.74 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106351069 | CMS |
| ABBVIE INC. | $28.30 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106351071 | CMS |
| ABBVIE INC. | $24.19 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106351073 | CMS |
| ABBVIE INC. | $16.98 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106351075 | CMS |
| ABBVIE INC. | $33.92 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106351077 | CMS |
| ABBVIE INC. | $31.32 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106351079 | CMS |
| BIOTISSUE HOLDINGS INC. | $17.51 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148752945 | CMS |
| Collegium Pharmaceutical, Inc. | $16.14 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135343738 | CMS |
| Nalu Medical, Inc. | $20.49 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133994879 | CMS |
| Nalu Medical, Inc. | $19.94 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133994877 | CMS |
| Nevro Corp. | $29.00 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758314 | CMS |
| Nevro Corp. | $27.28 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758320 | CMS |
| Nevro Corp. | $27.58 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758316 | CMS |
| Nevro Corp. | $26.82 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758296 | CMS |
| Nevro Corp. | $22.12 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758300 | CMS |
| Nevro Corp. | $21.38 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758326 | CMS |
| Nevro Corp. | $21.72 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758322 | CMS |
| Nevro Corp. | $26.27 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758334 | CMS |
| Nevro Corp. | $18.94 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758324 | CMS |
| Nevro Corp. | $27.31 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758312 | CMS |
| Nevro Corp. | $23.97 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758280 | CMS |
| Nevro Corp. | $18.73 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758318 | CMS |
| Nevro Corp. | $19.83 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758298 | CMS |
| Nevro Corp. | $32.55 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758328 | CMS |
| Nevro Corp. | $22.75 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758330 | CMS |
| Nevro Corp. | $20.92 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758306 | CMS |
| Nevro Corp. | $16.94 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758332 | CMS |
| Nevro Corp. | $20.88 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758308 | CMS |
| Nevro Corp. | $22.94 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758304 | CMS |
| Nevro Corp. | $22.51 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758338 | CMS |
| Nevro Corp. | $19.62 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758310 | CMS |
| Nevro Corp. | $21.39 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758294 | CMS |
| Nevro Corp. | $24.06 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130758302 | CMS |
| Pacira Pharmaceuticals Incorporated | $19.93 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151252595 | CMS |
| Saluda Medical Americas, Inc. | $9.87 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081871978 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.